MrMed Logo
Deliver to

Chennai, 600017

Available Brands

Did you find this information helpful?

Author Details
mrmed authentic

Want to know more?
Read Our Editorial Policy

Quick Summary

LETERMOVIR

LETERMOVIR

Molecule Overview

Letermovir is an antiviral medicine used to prevent cytomegalovirus (CMV) infection and disease in certain transplant recipients. It belongs to a new class of medicines that block CMV in a different way from older antivirals, avoiding some of their common side effects. It is a prescription-only medicine.

Medical Classification

Therapeutic Class: Antiviral medicine for cytomegalovirus (CMV) prophylaxis.

Pharmacological Class: CMV DNA terminase complex inhibitor (non-nucleoside).

Drug Family: 3,4-dihydro-quinazoline antivirals.

ATC Classification: J05AX18 (Letermovir).

Conditions Treated

Approved: Prophylaxis of CMV disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT); and prophylaxis of CMV disease in adult and pediatric kidney transplant recipients (12 years and older, weighing at least 40 kg) at high risk (donor CMV-seropositive/recipient CMV-seronegative).

Commonly used for: Transplant patients at risk of CMV reactivation or infection, as a preventive measure started around the time of transplant.

Off-label use (only under medical guidance): Sometimes explored for CMV prevention in other solid organ transplant settings under specialist guidance.

Available Strengths & Dosage Forms

●       Oral tablets: 240 mg and 480 mg.

●       Oral pellets: for pediatric patients unable to swallow tablets, in various lower strengths.

●       Injection (intravenous infusion): available for patients unable to take oral medication.

How the Molecule Works

Letermovir blocks a part of the CMV virus called the terminase complex, which the virus needs to correctly package its genetic material into new viral particles during replication. By inhibiting this specific step, letermovir prevents the virus from producing new infectious copies of itself, without affecting the same pathways that older CMV antivirals (like valganciclovir) act on — which is part of why it tends to cause less bone marrow suppression.

Dosage & Administration

  • Standard dose (HSCT prophylaxis): 480 mg orally or intravenously once daily, reduced to 240 mg once daily if co-administered with cyclosporine; typically started after transplant and continued through 100 days post-transplant.

  • Condition-wise dose (kidney transplant prophylaxis): 480 mg once daily (orally or intravenously), initiated between Day 0 and Day 7 post-transplant and continued through Day 200 post-transplant.

  • Route: Oral (tablet or pellets), with or without food, or intravenous infusion when oral dosing isn't possible.

  • Cyclosporine adjustment: If cyclosporine is started after letermovir, the next letermovir dose is reduced to 240 mg/day; if cyclosporine is stopped, the next letermovir dose is increased back to 480 mg/day.

  • Missed dose: Take as soon as remembered on the same day; don't double up — resume the regular schedule.

  • Overdose: Not established beyond recommended dosing; managed with supportive care and monitoring.

Side Effects

  • Common: Nausea, diarrhoea, vomiting, swelling in the limbs (peripheral edema), cough, headache, and fatigue.

  • Serious: Elevated liver enzymes, and, in rare cases, significant allergic reactions.

  • Emergency symptoms: Yellowing of the skin/eyes, severe abdominal pain, or signs of a serious allergic reaction (swelling of the face/throat, difficulty breathing).

  • Recovery advice: Common side effects like nausea are usually mild and manageable; unlike older CMV antivirals, letermovir does not typically cause significant bone marrow suppression, which is one of its key advantages.

Warnings & Precautions

  • Pregnancy: Used only if clearly needed, under medical guidance, as data are limited.

  • Breastfeeding: Discussed with the treating doctor given limited safety data.

  • Liver disease: Used with caution; not recommended with the IV formulation in severe hepatic impairment combined with moderate/severe renal impairment, due to a specific excipient concern.

  • Kidney disease: The IV formulation contains an excipient (hydroxypropyl betadex) that can accumulate in reduced kidney function; serum creatinine is monitored closely in patients receiving IV letermovir with significant renal impairment.

  • Elderly: Used with routine monitoring; no specific age-based dose adjustment required.

  • Children: Approved for kidney transplant CMV prophylaxis in patients 12 years and older weighing at least 40 kg, with weight-based dosing for lower weight bands using pellets or lower-dose IV.

Drug Interactions

●       Pimozide and ergot alkaloids: contraindicated in combination with letermovir due to the risk of serious toxicity.

●       Cyclosporine: significantly increases letermovir levels, requiring the letermovir dose to be reduced to 240 mg/day.

●       Certain statins (e.g., simvastatin, atorvastatin): letermovir can increase their levels, requiring dose adjustment or closer monitoring.

●       CYP3A4/2C9 substrates and other transporter-affected drugs: numerous interactions are possible given letermovir's effect on drug-metabolising enzymes and transporters — a full medication review is recommended before starting.

Monitoring Requirements

●       Liver function tests periodically.

●       Serum creatinine monitoring in patients receiving IV letermovir with reduced kidney function.

●       CMV viral load monitoring as part of standard post-transplant surveillance.

●       Cyclosporine level monitoring when used together, given the two-way interaction.

Alternative Molecules

Valganciclovir, Ganciclovir (older CMV antivirals with a different mechanism and more bone marrow suppression risk); Foscarnet, Cidofovir (used for resistant CMV or specific clinical situations).

Combination Therapies

In kidney transplant CMV prophylaxis studies, letermovir has been used alongside acyclovir (for other viral prophylaxis needs); dose adjustment is specifically required when combined with cyclosporine, one of the standard immunosuppressants used post-transplant.

●       Cytomegalovirus (CMV) Prophylaxis

●       Transplant Supportive Care

●       Antiviral Therapies

FAQs

Q1.

What is letermovir used for?

It's used to prevent CMV infection and disease in adult stem cell transplant recipients who are CMV-seropositive, and in high-risk adult (and certain pediatric) kidney transplant recipients.

Q2.

How is letermovir different from older CMV medicines like valganciclovir?

It works through a different mechanism (blocking the CMV terminase complex) and generally causes less bone marrow suppression, making it a preferred option for CMV prevention in many transplant settings.

Q3.

Why does the dose change with cyclosporine?

Cyclosporine significantly raises letermovir levels in the blood, so the letermovir dose is halved (to 240 mg) when the two are taken together to avoid excess exposure.

Q4.

Can letermovir be taken with food?

Yes, the oral tablet can be taken with or without food.

Q5.

How long is letermovir typically continued after transplant?

This depends on the transplant type — commonly through 100 days post-transplant for stem cell transplant recipients, or through 200 days post-transplant for high-risk kidney transplant recipients.

Disclaimer

The information on this page is for educational purposes only and is not a substitute for medical advice. Please consult your doctor to know if this treatment is appropriate for your condition.

;

Why MrMed?

Directly from

Directly from
Manufacturers

Quick Air

Quick Air
Delivery

Genuine

Genuine
Medicines

Up-to 85%

Up-to 85%
Discount

Why MrMed?

  • Genuine Medicines — Sourced from licensed manufacturers and their authorised distributors, with quality checks at every step.

  • Cold Chain Delivery — Temperature-controlled shipping for medicines that need it, to 4,000+ towns and cities across India.

  • Hard-to-Find Medicines — If a medicine is not available in India, we help you source it and support the documentation and approvals required.

  • Up to 85% Savings — Speciality treatments at a fraction of MRP.

We Create a Way. For You.

Serving customers and shipping medicines only within India.

Living with a serious health condition comes with enough challenges. Finding the right medicine shouldn't be one of them.

MrMed helps patients and caregivers in India buy speciality medicines online for cancer, kidney disease, heart conditions, and other complex long-term illnesses. If a prescribed medicine isn't available in India, we also help source and import it from trusted global suppliers while managing the required documentation and approvals.

From genuine medicine sourcing and cold chain delivery to patient support services, we make it easier to access treatment with confidence. Every step is built around one goal: helping you get the medicines you need, when you need them.

Why Patients Trust MrMed

  • 7,000+ speciality medicines across multiple therapeutic areas like oncology, nephrology, cardiology, and critical care medicines

  • Delivery to 4,000+ towns and cities across India

  • Up to 85% savings on speciality medicines

  • Medicines sourced from licensed manufacturers and authorised suppliers

  • Secure ordering through the MrMed website and app

  • Dedicated support for patients and caregivers

MrMed by the Numbers

The trust placed in MrMed is reflected in the lives we've been able to support.

  • ₹125+ crores saved by our users

  • ₹75 saved every second on cancer medicine, heart conditions, and more

  • Helping patients access treatment across India

Beyond Medicine Delivery

We support patients throughout their treatment journey with services that go beyond medicine delivery.

  • Guidance on Patient Assistance Programs (PAPs)

  • Support for accessing prescribed imported medicines

  • Dedicated customer support before and after your order

  • Assistance in finding difficult-to-access speciality medicines

Recognised for Excellence

MrMed has been recognised by leading industry platforms for our work in improving access to speciality healthcare through trust, innovation, and responsible care.

  • Healthcare Start-up of the Year by the Federation of Indian Chambers of Commerce & Industry (FICCI)

  • ET Pharma Game Changer Award for our contribution to speciality healthcare access

  • Selected for the Google Play Accelerator India 2026 Cohort, joining 20 AI-first startups chosen by Google

  • BW Healthcare 40 Under 40 recognition received by our founders, Dev and Saurab, in different years

  • Recognised among Brands to Watch Out For by Local Samosa

Trusted Healthcare, Verified Standards

MrMed is LegitScript Certified, reflecting our commitment to trusted, transparent, and responsible healthcare services. This certification reinforces our focus on maintaining high standards in online healthcare practices and patient safety.

Start Your Treatment Journey with Confidence

Whether you're ordering a regular prescription or looking for a difficult-to-find speciality medicine, MrMed is here to help.

Explore our catalogue and order medicines online with confidence through the MrMed website or app.

Download the MrMed App For Super-Fast Delivery!

MrMed is India's largest online pharmacy for super speciality medicines, offering an extensive range of drugs that cater to diverse health needs across the country.

MrMed

Genuine medicines delivered all over India

MrMed

Sourced directly from reputable manufacturers

MrMed

Efficient storage for temperature-sensitive medicines

MrMedMrMed

Available on Google Play & App Store